Literature DB >> 22430112

Multiple sclerosis: Multiple sclerosis therapy--vitamin D under spotlight.

Iley Ozerlat.   

Abstract

Entities:  

Year:  2012        PMID： 22430112     DOI： 10.1038/nrneurol.2012.37

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  3 in total

1.  A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.

Authors:  Merja Soilu-Hänninen; Julia Aivo; Britt-Marie Lindström; Irina Elovaara; Marja-Liisa Sumelahti; Markus Färkkilä; Pentti Tienari; Sari Atula; Taneli Sarasoja; Lauri Herrala; Irma Keskinarkaus; Johanna Kruger; Timo Kallio; Maria A Rocca; Massimo Filippi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-02-22       Impact factor: 10.154

2.  Rare variants in the CYP27B1 gene are associated with multiple sclerosis.

Authors:  Sreeram V Ramagopalan; David A Dyment; M Zameel Cader; Katie M Morrison; Giulio Disanto; Julia M Morahan; Antonio J Berlanga-Taylor; Adam Handel; Gabriele C De Luca; A Dessa Sadovnick; Pierre Lepage; Alexandre Montpetit; George C Ebers
Journal:  Ann Neurol       Date:  2011-12       Impact factor: 10.422

3.  Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial.

Authors:  Margitta T Kampman; Linn H Steffensen; Svein I Mellgren; Lone Jørgensen
Journal:  Mult Scler       Date:  2012-02-21       Impact factor: 6.312
  3 in total
  1 in total

1.  Sex-Specific Gene-by-Vitamin D Interactions Regulate Susceptibility to Central Nervous System Autoimmunity.

Authors:  Dimitry N Krementsov; Loredana Asarian; Qian Fang; Mahalia M McGill; Cory Teuscher
Journal:  Front Immunol       Date:  2018-07-17       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.